Knome announced today that it is taking orders for the knoSYS™100,
the first plug-and-play, fully integrated hardware and software system
designed to help researchers in medical and academic institutions
interpret human whole genomes. The knoSYS™100 was developed to help
geneticists discover relevant genetic variation, investigate diseases of
unknown cause, and create next generation in silico gene tests.
Units will begin shipping in Q4, 2012.
From Knome: knoSYS(TM)100, the first plug-and-play, fully integrated hardware and software system designed to help researchers in medical and academic institutions interpret human whole genomes. The knoSYS(TM)100 was developed to help geneticists discover relevant genetic variation, investigate diseases of unknown cause, and create next generation in silico gene tests. (Photo: Business Wire)
Starting at $125,000, the knoSYS™100 is based on Knome's big data
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in